| ²é¿´: 86 | »Ø¸´: 1 | |||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | |||
[½»Á÷]
Âõ Ïò 21 ÊÀ ¼Í µÄ ÄÉ Ã× Ò½ ѧ
|
|||
|
THE NANO MEDICINE IS GOING TO 21TH CENTURY Âõ Ïò 21 ÊÀ ¼Í µÄ ÄÉ Ã× Ò½ ѧ -------------------------------------------------------------------------------- Ææ ÔÆ £¨°²»ÕÊ¡»´ÄÏְҵҽר¸±½ÌÊÚ£¬»´ÄÏÊÐ232001£© ÕªÒª£ºÆÀÊöÁËÄÉÃ×ҽѧµÄÀíÂÛ¡¢Ó¦ÓÃÒâÒå¡¢Ñо¿ÁìÓòºÍ×îнøÕ¹¡£ ¹Ø¼ü´Ê£ºÄÉÃ×£¬ÄÉÃ׿Ƽ¼£¬ÄÉÃ×ҽѧ 1. ¿çÊÀ¼ÍµÄÐÂѧ¿Æ¡ª¡ªÄÉÃ׿Ƽ¼ 2. ¿ª±ÙÄÉÃ׿Ƽ¼ÐÂÁìÓò¡ª¡ª¹ØÓÚÄÉÃ×ҽѧµÄÃüÌâ¼°±ØÒªÐÔ 3. ÄÉÃ×ҽѧµÄ¹Ø¼ü¼¼Êõ 4 ÄÉÃ×ҽѧµÄÑо¿ÄÚÈÝ 4.1 Ã÷²ìÇïºÁ¡ª¡ªÔÚÄÉÃ׳߶ÈÉÏ»ñÈ¡ÉúÃüÐÅÏ¢ 4.2 ³¬Ô½¼«ÏÞ¡ª¡ª¿ª·¢ÎïÖÊDZÔÚµÄÐÅÏ¢½á¹¹Ç±Á¦ 4.3 ²ÄÁÏ´´Ð¡ª¡ª¿ªÍØÒ½Ò©ÐÂÁìÓò 4.4 ÄÉÃ×»úÆ÷¡ª¡ªÍƶ¯Ò½Ñ§½ø²½µÄ¶¯Á¦ 5 ¿ª´´ÄÉÃ×ҽѧмÍÔª ²Î ¿¼ ÎÄ Ï× 1. ÆæÔÆ. ´´ÔìÆæ¼£µÄÄÉÃ׿Ƽ¼£¬ÊÀ½ç·¢Ã÷£¬1992£¬15£¨7£©£º5-6 2. ÆæÔÆ. ÄÉÃ׿Ƽ¼µÄÓÕÈËǰ¾°£¬±±¾©¿Æ¼¼±¨£¬1992Äê9ÔÂ23ÈÕ£¬µÚ1508ÆÚµÚ3°æ 3. ÆæÔÆ. ÄÉÃ׿Ƽ¼¡ª¡ªÈËÀàмÍÔª£¬ÖйúÇàÄ걨£¬19937ÔÂ3ÈÕ£¬µÚ7363ÆÚµÚ3°æ 4. ÆæÔÆ. Ô×ӳߴçµÄ¡°ÒÕÊõ¡±´´×÷£¬·¢Ã÷Óë¸ïУ¬1993£¨3£©£º21-21 5. ÆæÔÆ. ÄÉÃ×ҽѧ¡ª¡ª21ÊÀ¼ÍµÄ¿Æ¼¼ÐÂÁìÓò£¬ÖйúÒ½Ò©±¨£¬1995Äê6ÔÂ8ÈÕ~1995Äê7ÔÂ18ÈÕ£¬µÚ1160ÆÚ-1178ÆÚ£¬µÚ7°æ 6. ÆæÔÆ. ÉúÎï¿ÆÑ§Ñо¿µÄÐÂÁìÓò¡ª¡ªÄÉÃ×ÉúÎïѧ£¬ÖйúÒ½Ò©±¨£¬1992Äê10ÔÂ29ÈÕ£¬µÚ816ÆÚµÚ4°æ 7. ÆæÔÆ. ÄÉÃײÄÁÏ¡ª¡ª21ÊÀ¼ÍµÄвÄÁÏ£¬¿Æ¼¼µ¼±¨£¬1992£¨10£©£º28-31 8. ÆæÔÆ. ÄÉÃ×µç×ÓѧչÍû£¬µç×ÓÊÀ½ç£¬1992£¨12£©£º2-3 9. ÆæÔÆ. ÄÉÃ×ÉúÎïѧµÄÓÕÈËǰ¾°£¬¹âÃ÷ÈÕ±¨£¬1993Äê5ÔÂ7ÈÕ£¬µÚ15864ºÅµÚ3°æ 10. ÆæÔÆ. ÄÉÃ×»¯Ñ§Ñо¿½øÕ¹£¬×ÔÈ»ÔÓÖ¾£¬1993£¬16£¨9¡¢10£©£º2-5 11. ÆæÔÆ. ÄÉÃ×µç×ÓѧÑо¿½øÕ¹£¬ÏÖ´úÎïÀí֪ʶ£¬1994£¬6£¨5£©£º24-25 12. ÆæÔÆ. ÄÉÃ×»¯Ñ§Ñо¿½øÕ¹£¬ÏÖ´ú»¯¹¤£¬1993£¬13£¨8£©£º38-39 13. ÆæÔÆ. ÄÉÃ׿Ƽ¼µÄÖØÒª·ÖÖ§¡ª¡ªÄÉÃ×µç×Óѧ£¬ÊÀ½ç¿Æ¼¼£¬1994£¬£¨8£©£º6-8 14. ÆæÔÆ. ո¶ͷ½ÇµÄÄÉÃ×»¯Ñ§£¬Öйú¿ÆÐ±¨£¬1993Äê11ÔÂ4ÈÕµÚ44ºÅµÚ3°æ 15. ÆæÔÆ. ÄÉÃ×ÉúÎïѧ¡ª¡ªÒ»ÃÅոеĿÆÑ§¼¼Êõ£¬ÉúÎïѧ½Ìѧ£¬1994£¬£¨1£©£º2-4 16. ÆæÔÆ. ÄÉÃ×µç×Óѧǰ¾°ÓÕÈË£¬¸ßм¼Êõ²úÒµ±¨£¬1994Äê3ÔÂ4ÈÕµÚ18ÆÚµÚ3°æ 17. Ò×¼Ò¿µ£¬Òë. ÄÉÃ×ҽѧ£¬ÊÀ½ç¿ÆÑ§£¬2000£¨4£©£º21 18. ¶ÅÕ¼ÎÄ£¬±àÒë.ÕýÔÚ×ß½üÁÙ´²µÄÄÉÃ×ҽѧ£¬¹úÍâ¿Æ¼¼¶¯Ì¬£¬2000£¬£¨9£©£º28-29 19. ²Üѧ¾ü£¬´Þ½ðÌ©. ÉñÆæµÄÄÉÃ×¼¼Êõ£ºÓÃÔ×ÓËÜÔìÊÀ½ç£¬¹úÍâ¿Æ¼¼¶¯Ì¬£¬2000£¬£¨9£©£º35 20. ÆæÔÆ. ¼¤¹âÏÝÚå¼°ÆäÔÚÉúÎïҽѧÁìÓòÖеÄÓ¦Óã¬ÉúÎïѧÔÓÖ¾£¬1995£¬£¨1£©£º14-16 21. Mirkin CA£¬Letsinger RL£¬Mucic RC£¬et al. A DNA-based method for rationally assembling nanoparticles into macroscopic materials.Nature£¬1996£¬382£¨6592£©£º607-609 22. Alivisatos AP£¬Johnssorr KP£¬Peng X £¬ et al. Organization of ¡®nanocrystal¡¯ using DNA.Nature£¬1996£¬382£¨6592£©£º609-611 23. Schofield JP£¬ Caskey CT. Non-viral approaches to gene therapy. Br Merd Bul £¬1995£»51£¨1£©£º56-71 24. Borchard G£¬ Kreuter J. The role of serum complement on the organ distribution of intravenously administered poly£¨methyl methacrylate£©nanoparticles£ºeffects of pre-coating with plasma and with serum complement . Pharm Res £¬1996£»13£¨7£©£º1055-1058** 25. Tiefenauer LX, Tschirky A, KKne G, et al. Invivo evaluation of magnetite nanoparticles for use as a tumor contrast agent in MRI. Magn Reson Imaging ,1996;14(4):391-394 26. Gref R, Minamitake Y, Peracchia MT, et al . Biodegradable long-circulating polymeric nanospheres. Science,199 [ Last edited by zjun on 2006-2-12 at 15:18 ] |
» ²ÂÄãϲ»¶
Ò£¸Ð²âѹ
ÒѾÓÐ0È˻ظ´
ѧÊõÇóÖú
ÒѾÓÐ0È˻ظ´
·ÅÉäҽѧÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ295È˻ظ´
381Ò»Ö¾Ô¸ÖÐÖ×Çóµ÷¼Á£¡£¡
ÒѾÓÐ0È˻ظ´
¼ª´ó¹«ÎÀ357Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
ÁÙ´²Ò½Ñ§313·Ö Ò»×÷Ò»Çøsci ÇóҽѧԺר˶µ÷¼ÁÊÕÁô
ÒѾÓÐ3È˻ظ´
Çó¾«Í¨crisper/cas9µÄ´óÀаïÖú
ÒѾÓÐ0È˻ظ´
Ò»Ö¾Ô¸Öдó¹«ÎÀÇóµ÷¼Á
ÒѾÓÐ8È˻ظ´
Öдó¹«ÎÀ303·ÖÇóµ÷¼Á
ÒѾÓÐ11È˻ظ´
» ±¾Ö÷ÌâÏà¹ØÉ̼ÒÍÆ¼ö: (ÎÒÒ²ÒªÔÚÕâÀïÍÆ¹ã)
madahaa
Òø³æ (³õÈëÎÄ̳)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 259.8
- ºì»¨: 1
- Ìû×Ó: 49
- ÔÚÏß: 2.7Сʱ
- ³æºÅ: 180259
- ×¢²á: 2006-02-09
- ÐÔ±ð: GG
- רҵ: Íâ¹úÓïÑÔ
2Â¥2006-02-13 15:08:45














»Ø¸´´ËÂ¥




